198 related articles for article (PubMed ID: 21308718)
1. Construction of tissue micro array from prostate needle biopsies using the vertical clustering re-arrangement technique.
Fridman E; Daya D; Srigley J; Whelan KF; Lu JP; Pinthus JH
Prostate; 2011 Sep; 71(13):1374-81. PubMed ID: 21308718
[TBL] [Abstract][Full Text] [Related]
2. Construction of tissue microarrays from prostate needle biopsy specimens.
Jhavar S; Corbishley CM; Dearnaley D; Fisher C; Falconer A; Parker C; Eeles R; Cooper CS
Br J Cancer; 2005 Aug; 93(4):478-82. PubMed ID: 16091762
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of constructing tissue microarrays from diagnostic prostate biopsies.
Singh SS; Mehedint DC; Ford OH; Maygarden SJ; Ruiz B; Mohler JL
Prostate; 2007 Jul; 67(10):1011-8. PubMed ID: 17476688
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
5. Construction of tissue microarrays using pre-existing slides as source of tissue when paraffin blocks are unavailable.
Deng FM; Zhao Y; Kong X; Lee P; Melamed J
J Clin Pathol; 2013 Jul; 66(7):627-9. PubMed ID: 23476078
[TBL] [Abstract][Full Text] [Related]
6. Partial atrophy on prostate needle biopsy cores: a morphologic and immunohistochemical study.
Wang W; Sun X; Epstein JI
Am J Surg Pathol; 2008 Jun; 32(6):851-7. PubMed ID: 18408595
[TBL] [Abstract][Full Text] [Related]
7. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy.
Carswell BM; Woda BA; Wang X; Li C; Dresser K; Jiang Z
Histopathology; 2006 May; 48(6):668-73. PubMed ID: 16681682
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.
Olivier J; Stavrinides V; Kay J; Freeman A; Pye H; Ahmed Z; Carmona Echeverria L; Heavey S; Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Gelister J; Hawkes D; Hu Y; Jameson C; McCartan N; Punwani S; van der Muelen J; Moore C; Emberton M; Ahmed HU; Whitaker HC
Prostate; 2018 Dec; 78(16):1229-1237. PubMed ID: 30073682
[TBL] [Abstract][Full Text] [Related]
9. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
King CR; McNeal JE; Gill H; Presti JC
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
[TBL] [Abstract][Full Text] [Related]
10. An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.
Sanderson SO; Sebo TJ; Murphy LM; Neumann R; Slezak J; Cheville JC
Am J Clin Pathol; 2004 Feb; 121(2):220-5. PubMed ID: 14983935
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
Weinstein MH; Signoretti S; Loda M
Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
[TBL] [Abstract][Full Text] [Related]
12. [Tissue microarray--an infrastructure for prostate cancer outcome research].
Zisman A; Rozin LS; Stav K; Merded H; Lindner A; Sandbank J
Harefuah; 2005 Sep; 144(9):622-5; 677. PubMed ID: 16218532
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.
Molinié V; Hervé JM; Lugagne PM; Lebret T; Botto H
BJU Int; 2006 May; 97(5):1109-15. PubMed ID: 16643500
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of prostate needle biopsies using saved interval sections vs new recut sections from the block: a prospective comparison.
Hameed O; Humphrey PA
Am J Clin Pathol; 2009 May; 131(5):683-7. PubMed ID: 19369628
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
17. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
[TBL] [Abstract][Full Text] [Related]
18. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
19. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]